FSTL3 also plays a role in the development of different types of malignancies, including hepatocellular carcinoma (Grusch et al. 2006), breast cancer (Bloise et al. 2009), and NSCLC (Nishimura et al. 1982). Here, FSTL3 is linked to breast carcinoma.